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Abstract: Endotoxins (lipopolysaccharides, LPS) are one of the strongest immunostimulators in nature, responsible for 
beneficial effects at low, and pathophysiological effects at high concentrations, the latter frequently leading to sepsis and 
septic shock associated with high mortality in critical care settings. There are no drugs specifically targeting the patho-
physiology of sepsis, and new therapeutic agents are therefore urgently needed. The lipopolyamines are a novel class of 
small molecules designed to sequester and neutralize LPS. To understand the mechanisms underlying the binding and 
neutralization of LPS toxicity, we have performed detailed biophysical analyses of the interactions of LPS with candidate 
lipopolyamines which differ in their potencies of LPS neutralization. We examined gel-to-liquid crystalline phase behav-
ior of LPS and of its supramolecular aggregate structures in the absence and presence of lipopolyamines, the ability of 
such compounds to incorporate into different membrane systems, and the thermodynamics of the LPS:lipopolyamine 
binding. We have found that the mechanisms which govern the inactivation process of LPS obey similar rules as found for 
other active endotoxin neutralizers such as certain antimicrobial peptides.  
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INTRODUCTION 
 Infectious diseases continue to be a major cause of pre-
ventable mortality worldwide. Alarming increases in the 
incidence of multi-drug resistance in the face of a dwindling 
pipeline of new antibiotics is perhaps a scenario that Fleming 
could not have contemplated. Indeed, the incidence of sepsis 
continues to increase worldwide which may, in part, be at-
tributable to compromised efficacy of existing antibiotics. 
Inadequate antimicrobial chemotherapy may lead to a release 
of bacterial pathogenicity factors such as lipopolysaccharides 
(LPS, endotoxins) and lipoproteins (LP) [1-3]. Moreover, in 
some common viral infections such as influenza, it is known 
that cases with severe outcome are in most cases due to a 
superinfection, i.e., the initial viral infection is followed by a 
bacterial infection, an example being the ‘Spanish flu’ in the 
1920’s, in which millions of victims did not die from pri-
mary infection with influenza H1N1 [4], but from the subse-
quent bacterial infections, often leading to sepsis [5-7]. 
 Two recent approaches in addressing this urgent, unmet 
medical need are the use of anti-LPS or anti-LP compounds,  
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which have bind to, and neutralize these toxins so that they 
are no longer able to interact with upstream binding proteins 
such as lipopolysaccharide-binding protein (LBP), CD14, 
and the TLR4/MD2 complex, thereby preventing the activa-
tion of proinflammatory responses in target cells such as 
monocytes and macrophages. Notable examples of such 
sequestering compounds are the antimicrobial peptides 
termed synthetic anti-LPS peptides (SALP) [8,9] and the 
lipopolyamines (LPA) [10-15]. The biophysical mechanisms 
of the endotoxin:SALP interaction was published in recent 
reports [8,16]. In these reports it was found that the driving 
force of the interaction is the Coulomb attraction between the 
cationic groups of the SALP and the negative charges of the 
endotoxin with a subsequent intercalation of the hydrophobic 
moiety of the SALP into the lipid A moiety of LPS, inducing 
a change of the aggregate structure of the latter into a multi-
lamellar assembly [8,9,16]. For the LPA:endotoxin interac-
tion, such data are lacking. A detailed understanding of the 
biophysical correlates of mechanisms underlying the com-
plexation of LPA with LPS, and subsequent neutralization of 
endotoxicity is of particular relevance to further optimize 
efficacy. Hence, the main focus of this study was to obtain a 
detailed characterization of the neutralization mechanisms of 
LPS by LPA. The data show similar effects as published for 
SALP, from which the general structural correlates for effec-
tive anti-endotoxin action can be deduced. 
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MATERIALS AND METHODS 
Lipids and Lipopolysaccharides 
 Lipopolysaccharides from Salmonella minnesota rough 
Re and Ra, strains R595 and R60, respectively, were ex-
tracted from the bacteria grown at 37 °C by the phe-
nol:chloroform: petrol ether (PCP) method, purified, and 
used in the natural salt form [17]. The purity was examined 
by MALDI-TOF mass spectrometry, and LPS samples were 
only used when the chemical structure in particular of the 
lipid A part consisted of a diglucosamine, to which six acyl 
chains in amide and ester-linkage at positions 2 and 2’, and 3 
and 3’, respectively were bound and which were phosphory-
lated at positions 1 and 4’, according to the known structure 
of lipid A [18,19]. 
 For all experiments except the SAXS measurememts (see 
below), as endotoxin LPS Ra was taken since this compound 
is within the heterogeneous LPS wild-type the bioactive 
compound [16,19]. 
 The phospholipids phosphatidylcholine (PC) and phos-
phatidylserine (PS) were purchased from Avanti Polar Lipids 
(Alabaster, Al, USA). The lipopolyamines YAN-673, DS-
347 and DS-176 (Schemes 1, 2 and 3) were synthesized 
starting from DS-96 [14] as follows.  
 Synthesis of Yan-673 (Scheme 1): To a solution of DS-96 
(0.3 g, 0.285 mmol) in anhydrous methanol (30 mL) at room 
temperature was added acrylonitrile (0.188 mL, 2.85 mmol), 
triethylamine (0.198 mL, 1.43 mmol) and the mixture was 
stirred at room temperature for 8 h. The resulting solution 
was concentrated in vacuum, and purified by flash column 
chromatography (MeOH: DCM = 10:90) to give the color-
less oil YAN-673 (0.2 g, 87.7%). 1H NMR (500 MHz, 
CDCl3) δ 2.85 (t, J = 6.7 Hz, 4H), 2.80 – 2.72 (m, 8H), 2.62 
(t, J = 6.9 Hz, 2H), 2.56 – 2.40 (m, 27H), 1.65 – 1.54 (m, 
6H), 1.51 – 1.37 (m, 6H), 1.32 – 1.21 (m, 27H), 0.87 (t, J = 
6.9 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 119.5, 119.4, 
119.3, 118.8, 53.8, 53.63, 53.61, 51.6, 51.5, 51.1, 50.9, 49.6, 
49.5, 49.4, 49.3, 49.2, 31.9, 29.7, 29.68, 29.67, 29.6, 29.4, 
27.4, 27.1, 25.4, 25.1, 24.9, 22.7, 16.9, 16.7, 16.6, 16.5, 16.3, 
14.1. MS (ESI) calculated for C47H83N11, m/z 801.6833, 
found 802.7576 (M + H) +. 
 Synthesis of DS-347 (Scheme 2): To a solution of tri-Boc 
spermine 1 (0.65 g, 1.29 mmol), which was synthesized from 
spermine using a reported procedure [20], was added acetic 
acid (0.1 mL) in anhydrous methanol (30 mL) followed by 
the addition of biphenyl-4-carboxaldehyde (0.23 g, 1.26 
mmol), and sodium cyanoborohydride (0.120 g, 1.91 mmol). 
The colorless solution was stirred at room temperature for 24 
h. The solution was concentrated under reduced pressure, 
and the residue was extracted with dichloromethane (3 × 50 
mL). The combined organic layers were washed with brine 
and dried over anhydrous Na2SO4. After removal of the 
solvent under high vacuum, the crude biphenyl amino de-
rivative was dissolved in methanol (20 mL) to which a solu-
tion of di-tert-butyl dicarbonate (1.3 g, 5.96 mmol) in 
methanol (5 mL) was added. Removal of solvent and purifi-
cation of the crude product by column chromatography 
(Hexane:EtOAc = 25:75) provided the compound 2 as a 
colorless oil. The compound 2 (0.5 g, 0.651 mmol) was dis-
solved in anhydrous trifluoroacetic acid (20 mL) and stirred 
at room temperature for 30 min. The solvent was removed by 
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purging nitrogen and the residue was washed with diethyl 
ether to obtain the white solid DS-347 as tetra trifluoroace-
tate salt (0.461 g, 86%). 1H NMR (400 MHz, DMSO) δ 9.22 
(s, 1H), 8.88 (bs, J = 6.4, 3.4, 1.8 Hz, 2H), 7.97 (bs, J = 0.7 
Hz, 2H), 7.75 (d, J = 8.0 Hz, 2H), 7.69 (d, J = 7.8 Hz, 2H), 
7.58 (d, J = 8.0 Hz, 2H), 7.49 (t, J = 7.6 Hz, 2H), 7.40 (t, J = 
7.2 Hz, 1H), 4.21 (s, 2H), 3.14 – 2.78 (m, 12H), 2.09 – 1.96 
(m, 2H), 1.95 – 1.82 (m, 2H), 1.63 (s, 4H). 13C NMR (101 
MHz, DMSO) δ 141.3, 139.8, 131.4, 131.0, 129.5, 128.3, 
127.4, 127.2, 50.2, 46.6, 44.4, 44.3, 44.2, 36.7, 24.3, 23.1, 
22.9. MS (ESI) calculated for C23H36N4, m/z 368.2940, 
found 369.3060 (M + H) +.  
 Synthesis of DS-176 (Scheme 3): To a solution of β-
alanine methyl ester hydrochloride (3.5 g, 25.07 mmol) in 
anhydrous methanol (30 mL) was added acrylonitrile (1.65 
mL, 33.9 mmol) and the mixture stirred at room temperature 
for 15 h. After removal of solvent under high vacuum, the 
crude nitrile derivative was dissolved in 30 mL of methanol 
followed by the addition of di-tert-butyl dicarbonate (10.94 
g, 50.14 mmol). The resulting solution was stirred for 8 h at 
room temperature, concentrated in vacuum, and purified by 
flash column chromatography (EtOAc:Hexane = 14:86) to 
give a colorless oil 2. The mono-nitrile derivative 2 (1.9 g, 
7.42 mmol) and hexadecylamine (5.4 g, 22.26 mmol) in 
methanol (25 mL) was hydrogenated over Pd(OH)2/C s cata-
lyst at 2.76 bar pressure for 12 h. The catalyst was filtered on 
celite and the solvent was removed under reduced pressure, 
which was used for the next step without purification. To this 
crude compound in methanol (20 mL) were added di-tert-
butyl dicarbonate (7.00 g, 32.00 mmol) and triethylamine 
(1.04 mL, 7.42 mmol). The resulting solution was stirred for 
2 h at room temperature. The solvent was then removed 
under reduced pressure and purified by flash column chro-
matography (EtOAc: Hexane = 10:90) to give the methyl 
ester derivative (3.78 g, 6.46 mmol) as a viscous oil which 
was dissolved in THF (10 mL) followed by the addition of a 
solution of lithium hydroxide (0.47 g, 19.38 mmol) in water 
(20 mL). The resulting solution was stirred at room tempera-
ture for 24 h. The reaction mixture was extracted with chlo-
roform and the combined extracts were washed with water, 
brine, and dried over sodium sulfate. After removal of sol-
vent under vacuum, the residue was purified by flash column 
chromatography (MeOH: DCM = 10:90) to afford the com-
pound 3 as colorless oil (3.5 g). In a similar way the ester 
derivative 2 was hydrolysed with lithium hydroxide to give 
the compound 4. The compound 4 (4.76 g, 19.6 mmol) was 
then coupled with 1,3-diaminopropane (8.21 mL, 58.8 
mmol) in anhydrous dichloromethane using dicyclohexyl-
carbodiimide (4.1 g, 19.8 mmol) (DCC) and a catalytic 
amount of 4-(Dimethylamino)pyridine (DMAP) to give the 
crude amine 5. The crude amine 5 (1.6 g, 5.36 mmol) was 
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Schemes (1-3). Schematic presentation of the synthesis of the lipopolyamines.  
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finally coupled with the compound 3 (1.82 g, 3.2 mmol) in 
anhydrous dichloromethane using DCC (0.65 g, 3.15 mmol) 
and a catalytic amount of DMAP to give the nitrile deriva-
tive 6. The nitrile derivative 6 (1.46 g, 1.72 mmol) was hy-
drogenated over Pd(OH)2/C as catalyst at 2.76 bar pressure 
in glacial acetic acid (20 mL) for 12 h. Acetic acid was re-
moved under reduced pressure after filtration of the catalyst 
on celite followed by the addition of di-tert-butyl dicarbon-
ate (2.46 g, 11.3 mmol) in methanol (15 mL). After removal 
of solvent under vacuum, the residue was purified by flash 
column chromatography (MeOH:DCM = 4:96) to yield the 
protected amine derivative 7 as a colorless oil. The com-
pound 7 (1.16 g, 1.22 mmol) was dissolved in anhydrous 
trifluoroacetic acid (20 mL) and stirred at room temperature 
for 30 min. The solvent was removed by purging nitrogen 
and the residue was washed with diethyl ether to obtain the 
white solid DS-176 as tetra trifluoroacetate salt (1.0 g, 
81.3%). 1H NMR (500 MHz, DMSO) δ 8.86 – 8.62 (m, 6H), 
8.18 (t, J = 5.4 Hz, 2H), 7.95 (s, 3H), 3.16 – 3.05 (m, 8H), 
2.99 (s, 6H), 2.88 (s, 4H), 1.98 – 1.85 (m, 4H), 1.60 – 1.51 
(m, 4H), 1.32 – 1.19 (m, 26H), 0.85 (t, J = 6.9 Hz, 3H). 13C 
NMR (126 MHz, DMSO) δ 168.8, 46.7, 44.0, 43.9, 43.8, 
43.0, 36.4, 36.1, 31.3, 30.9, 30.8, 29.01, 29.0, 28.90, 28.88, 
28.8, 28.7, 28.5, 25.8, 25.4, 23.6, 22.2, 22.1, 13.9. MS (ESI) 
calculated for C31H66N6O2, m/z 554.5247, found 555.4236 
(M + H) +. 
 Stimulation of human mononuclear cells by LPS: The 
stimulation of human mononuclear cells was performed as 
described previously [21,22]. Briefly, MNC were isolated 
from heparinized blood of healthy donors. The cells were 
resuspended in medium (RPMI 1640) at 5x106cells/ml. For 
stimulation, 200 µl MNC (1x106cells) were transferred into 
each well of a 96-well culture plate. LPS R60 and the 
LPS:lipopolyamine mixtures were preincubated for 30 min at 
37°C, and added to the cultures at 20 µl per well. The cul-
tures were incubated for 4 h at 37 °C under 5 % CO2. Super-
natants were collected after centrifugation of the culture 
plates for 10 min at 400xg and stored at –20 °C. TNF con-
centrations were quantified by a sandwich ELISA using a 
monoclonal antibody against TNF (clone 6b from Intex AG, 
Switzerland). 
 Fluorescence resonance energy transfer spectroscopy 
(FRET): The ability of the LPA to intercalate into phosphol-
ipid liposomes made from phosphatidylcholine (PC) or 
phosphatidylserine (PS) or into LPS R60 aggregates was 
investigated by FRET as described earlier [16]. Briefly, 
phospholipid liposomes or LPS R60 were doubly labelled 
with the fluorescent phospholipid dyes 1,2-dipalmitoyl-sn-
glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-
benzoxadiazol-4-yl), ammonium salt (NBD-PE) and N-
(lissamine rhodamine B sulfonyl)-phosphatidylethanolamine 
(Rh-PE) (Molecular Probes). Intercalation of unlabelled 
molecules into the doubly labelled liposomes leads to probe 
dilution and with that to a lower FRET efficiency: the emis-
sion intensity of the donor ID increases and that of the accep-
tor IA decreases (for clarity, only the quotient of the donor 
and acceptor emission intensity is shown here). In all ex-
periments, aliquots of the LPA (100 l of 100 M) were 
added to doubly labelled phospholipid liposomes or LPS 
R60 aggregates (900 l of 10 M) at 50 s after equilibration. 
NBD-PE was excited at 470 nm and the donor and acceptor 
fluorescence intensities were monitored at 531 and 593 nm, 
respectively, and the fluorescence signal ID/IA was recorded 
for further 250 s.  
 Isothermal Titration Calorimetry (ITC): Microcalorimet-
ric measurements of the binding of LPA to endotoxins were 
performed on a MCS isothermal titration calorimeter (Mi-
crocal Inc.) at 37 °C as described previously [23] LPS R60 
(0.05 mM) was dispersed into the microcalorimetric cell 
(volume 1.3 ml) and the LPA dispersions (1 mM) were filled 
into the syringe compartment (volume 100 µl). After tem-
perature equilibration, the LPA were titrated in 3 µl portions 
every 5 min into the lipid-containing cell under constant 
stirring, and the heat of interaction after each injection meas-
ured by the ITC instrument was plotted versus time.  
 X-ray scattering: For the determination of the aggregate 
structures of LPS, deep rough mutant LPS R595 was taken, 
since this also highly bioactive compound provides better 
resolved spectra than compounds with longer sugar chains 
[21]. Scattering patterns were determined in the absence and 
presence of the LPA using small-angle X-ray scattering 
(SAXS). Due to the amphiphilic nature of the LPA, they may 
aggregate by themselves and thus were measured also in 
uncomplexed form. SAXS measurements were performed at 
the European Molecular Biology Laboratory (EMBL) outsta-
tion at the Hamburg synchrotron radiation facility HASY-
LAB using the double-focusing monochromator-mirror cam-
era X33 [24]. Scattering patterns in the range of the scatter-
ing vector 0.001 < s < 0.08 Å-1 (s = 2 sin /, 2 scattering 
angle and  the wavelength = 0.15 nm) were recorded at 20, 
40, 60, and 80 °C with exposure times of 1 min using an 
image plate detector with online readout (MAR345, MarRe-
search, Norderstedt/Germany). The s-axis was calibrated 
with Ag-Behenate with a periodicity of 5.84 nm. The scatter-
ing patterns were evaluated as described previously[24] 
assigning the spacing ratios of the main scattering maxima to 
defined three-dimensional structures. The lamellar and cubic 
structures are most relevant in the present study. 
 Fourier-transform infrared spectroscopy (FTIR) FTIR 
was used to determine the gel to liquid crystalline phase 
transition of the hydrocarbon chains of LPS R60 by evaluat-
ing the peak position of the symmetric stretching vibration 
νs(CH2) in the wave number range 2850 to 2853 cm
-1. The 
infrared spectroscopic measurements were performed on an 
IFS-55 spectrometer (Bruker). LPS and LPS:LPA samples, 
dispersed in 20 mM Hepes buffer, pH 7.0, were placed in a 
CaF2 cuvette between 12.5 µm teflon spacers. The tempera-
ture-scans were performed automatically between 10 and 
70°C with a heating-rate of 0.6 °C/min. Every 3°C, 200 
interferograms were accumulated, apodized, Fourier trans-
formed, and converted to absorbance spectra.  
 Differential Scanning Calorimetry (DSC):Calorimetry 
measurements were performed with a VP-DSC calorimeters 
(MicroCal, Inc., Northampton, MA, USA) at a heating and 
cooling rate of 1 K·min-1 as described by us [25,26]. The 
DSC samples were prepared by dispersing a known ratio of 
LPS R60 to the polymer in 10 mM phosphate-buffered saline 
(PBS), 10 mM phosphate, 138 mM NaCl, 2.7 mM KCl) 
buffer at pH 7.4. The samples were hydrated in the liquid 
crystalline phase by vortexing. The measurements were 
performed in the temperature interval from 5 °C to 95 °C. In 
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the Figures, only the temperature range at which phase tran-
sitions were observed is shown. Five consecutive heating and 
cooling scans checked the reproducibility of the DSC ex-
periments of each sample. The accuracy of the DSC experi-
ments was ΔT = 0.1 °C for the main phase transition tem-
peratures and ΔH = 1 kJ·mol-1 for the main phase transition 
enthalpy. The DSC data were analyzed using the Origin 
software. The phase transition enthalpy was obtained by 
integrating the area under the heat capacity curve. 
RESULTS 
Lipopolyamines Syntheses 
 In the Schemes 1-3, the syntheses of the LPAs DS-96 and 
Yan-673 (Scheme 1), DS-347 (Scheme 2), and DS-176 
(Scheme 3) are shown. As can be seen, extensive Michael 
addition of DS96 yielded the analogue Yan673, in which all 
the amines are peralkylated (Scheme 1). Furthermore, in 
compound DS176 (Scheme 3) two of the internal secondary 
amines are replaced by amides, 
 For an understanding of the following results, it should 
be noted that all LPAs consists of two regions, one very 
apolar region and one with polar characteristics, which is 
important to know on the basis of the amphiphilic property 
of the lipid A part of LPS. However, in contrast to SALP the 
lipopolyamines do not bear free positive charges.  
Inhibition of LPS-induced Cytokine Induction: 
 The production of proinflammatory cytokines such as 
tumor necrosis factor-α (TNF-α) is an appropriate measure 
for an inflammation reaction induced by immune stimulants 
such as LPS R60. Therefore, the first set of experiments was 
performed to test the ability of the LPA to inhibit the LPS-
induced inflammation reaction by measuring the secretion of 
TNF-α in human mononuclear cells in the presence and 
absence of different concentrations of LPA (Fig. 1). As can 
be seen (Fig. 1, top), compounds DS-96 and DS-347 inhibit 
the cytokine production in a dose-dependent manner; at a 
[LPA]:[LPS] weight ratio of 100, the activity of LPS is al-
most completely abrogated. In contrast to this behaviour, the 
lipopolyamines DS-176 and Yan-673 (Fig. 1, bottom) do not 
inhibit the LPS-Induced TNF-α production, the latter even 
enhancing it at the two lower LPS concentrations.  
Gel to Liquid Crystalline Phase Behaviour of LPS 
 Enterobacterial LPS are known to exhibit a gel to liquid 
crystalline of the hydrocarbon chains at a temperature Tm = 
30 to 36 °C according to the sugar chain length for the dif-
ferent rough mutant LPS [27,28]. The influence of the LPA 
on the behaviour of LPS R60 was monitored by Fourier-
transform infrared spectroscopy (FTIR) by evaluating the 
peak position of the symmetric stretching vibrational band 
 
Fig. (1). Tumor-necrosis factor-α secretion by human mononuclear cells induced by LPS (from Salmonella minnesota strain R60) in the 
absence and presence of the lipopolyamines. Error bars (s.d.) were computed from quadruplicate samples. 
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around 2850 to 2853 cm-1 and by differential scanning calo-
rimetry (DSC) by measuring the melting heat of the hydro-
carbon chains at Tm . 
 Data of FTIR experiments are presented in Fig. (2) for 
LPS R60 in the absence and presence of DS176 (A) and 
DS347 (B). As can be seen, pure LPS shows a melting of the 
hydrocarbon chains at Tm= 36 °C, which decreases in the 
presence of the LPAs, with DS176 exhibiting a quite moder-
ate decrease to 28 °C at [LPS]:[DS176] 1:2 (weight%), 
whereas DS347 causes at the highest concentration a com-
plete disappearance of the phase transition. For both com-
pounds, the presence of the LPAs leads to an increase in 
fluidity (increase in the wavenumber values), which, how-
ever, is much higher for DS347 than for compound DS176. 
The results for compounds DS96 and Yan673 (not shown) 
are indicative for an only slight decrease in the Tm of LPS, 
but a decrease in the wavenumbers, whereas Yan673 be-
haves similar to compound DS347, i.e., a strong increase in 
the wavenumber values in the entire temperature range. 
Thus, there is apparently no correlation of these data to their 
biological action as shown in Fig. (1). 
 Figs (3A and B) summarize the results from the thermo-
tropic properties of LPS R60 with the polymers DS176 and 
DS347 from DSC experiments. Various heat capacity curves 
are shown from the pure lipid up to a LPS:LPA molar ratio 
of 1:1. The pure lipid LPS R60 shows a gel to liquid crystal-
line phase transition at ca. 32-33 °C, accompanied by an 
endothermic phase transition of ca. +20 kJ/mol. The pres-
 
Fig. (2). Gel-to-liquid crystalline phase transition of the hydrocarbon chains of LPS R60 at different concentrations of DS176 (A) and DS347 
(B) by Fourier-transform infrared spectroscopy. The peak position of the symmetric vibration of the methylene groups νs(CH2) is plotted 
versus temperature. In the gel phase, the wavenumber values lie at 2850 cm-1, in the liquid crystalline phase they are shifted to 2852.5 to 
2853.0 cm-1.  
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ence of the various polymers exerts differential effects on the 
thermotropic lipid properties. The presence of small amounts 
of DS176 reduces the main phase transition temperature of 
LPS by about 1.5-2 °C. Increasing the amount of DS176 up 
to a LPS R60: DS176 1:1 molar ratio has no major impact on 
the phase transition temperature. However, the analysis of 
the phase transition enthalpy shows that it increases from ca. 
20 kJ/mol for the pure lipid up to 29 kJ/mol for the 1:1 mix-
ture. A comparison of the results obtained in the presence of 
DS347 shows a completely different picture. With increasing 
amount of the lipopolyamine, the maximum of the phase 
transition temperature is reduced. Furthermore, it can also be 
seen that the phase transition enthalpy decreases with in-
creasing amount of polymer. A strong decrease in the phase 
transition enthalpy is observed at a LPS R60:DS347 molar 
ratio of 1:0.4 to 1:0.5. Above a molar ratio larger than 1:0.5, 
no phase transition is observed in the temperature range 
between 5-50 °C. Even when the samples are stored for 48 h 
at 4°C, there is no phase transition observed. 
Aggregate Structures of LPS: 
 It has been shown that the aggregate structure of LPS is a 
determinant of its ability to induce cytokine production in 
human immune cells [21,28] For unilamellar/cubic aggregate 
structures, the activity is high, whereas multilamellar struc-
tures are characteristic for the absence of bioactivity.  
 The aggregate structure of LPS was monitored by using 
small-angle X-ray scattering (SAXS) with synchrotron radia-
tion in the absence and presence of the LPAs. As LPS that 
from S. minnesota deep rough mutant R595 was taken, since 
this compound with its short sugar chain gives better re-
solved SAXS patterns than compounds with long sugar 
chains. SAXS patterns are shown for LPS R595 in the pres-
ence of DS176 (Fig. 4A) and of DS347 (Fig. 4B). For the 
LPS:DS176 system, SAXS patterns are indicative of only 
one broad intensity distribution between 0.1 and 0.35/nm, 
which corresponds to the existence of a LPS bilayer system, 
e.g, for a unilamellar structure which is frequently found for 
this endotoxin. Therefore, the addition of compound DS176 
does not change the LPS aggregate structure significantly. In 
the presence of DS347, the patterns exhibit reflections at 
equidistant ratios. Thus, for example, at 40 °C there are 4 
reflections with a main peak at 5.49 nm and further reflec-
tions at 2.72 nm = 5.49/2 nm, 1.81 nm = 5.49/3 nm, and 1.35 
nm = 5.49/4 nm, which are clearly indicative for the exis-
tence of a multilamellar structure of the LPS assembly.  
 The results for compound DS96 leads similar as for 
DS347 to the occurrence of reflections typical for a multi-
lamellar phase, whereas for Yan673 a complex superposition 
of various reflections are indicative of a non-lamellar aggre-
gate structure (not shown).  
Incorporation of Lipopolyamines Into lipid Aggregates: 
 Fluorescence resonance energy transfer (FRET) spectros-
copy was applied to detect the possible incorporation of the 
LPAs into phospholipid molecules characteristic for immune 
cells such as phosphatidylcholine (PC) and phosphatidylser-
ine (PS) as well as into LPS R60. Data are presented in Figs. 
(5) for LPS, PC, and PS (from top to bottom).  
 For LPS except for Yan673 all lipopolyamines incorpo-
rate similarly into the endotoxin aggregate. For PC, all four 
investigated LPAs exhibit clearly more or less the same 
tendency to incorporate into this phospholipid. In contrast, 
the intercalation of the LPAs is different for PS showing a 
strong effect for DS176 and DS96, and a much lesser effect 
 
Fig. (3). Gel-to-liquid crystalline phase transition of the hydrocarbon chains of LPS R60 at different concentrations of DS176 (A) and DS347 
(B) by differential scanning calorimetry. The heat capacity Cp is plotted versus temperature showing the enthalpy change at the phase transi-
tion temperature.  
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for DS347, whereas for Yan673 there is a slowly increasing 
incorporation which has not finished at the end of the obser-
vation time.  
 From these results it can be concluded that there is appar-
ently no direct correlation with the biological inhibition of 
the LPS stimulation by the single compounds.  
Binding Enthalpy and Stoichiometry of LPS:LPA  
Mixtures: 
 To study the kind of binding and its stoichiometry of the 
LPAs to LPS R60 dispersions, isothermal titration calo-
rimetry (ITC) was applied. In Figs. (6), the results for the 
two most active compounds DS96 (A) and DS347 (B) are 
shown: In both cases the interaction consists of only exo-
Fig. (4). Aggregate structures of LPS R595 in the presence of DS176 (A) and DS347 (B) in small-angle X-ray scattering (SAXS) experi-
ments with synchrotron radiation. The logarithm of the scattering intensity (logI) is plotted versus the scattering vector, s (=1/d, d, spacings 
of the reflections).  
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thermic processes which run into saturation with a sigmoidal 
shape characteristic for a one target model. The stoichiome-
try – half saturation values - lies for both compounds around 
[LPA]:[LPS] = 0.7 to 0.75 molar. This means that 7 to 7.5 
LPA molecules are sufficient for the saturation of 10 LPS 
molecules.  
DISCUSSION 
 We have performed biophysical analyses of the interac-
tions of lipopolyamines with LPS with a view to understand-
ing the structural correlates of neutralization of endotoxicity. 
We found clear differences in the inhibition of the LPS-
induced cytokine production (Fig. 1) for the four lipopoly-
amines that we elected to characterize. DS96 has previously 
shown to be an excellent LPS neutralizer [12-14,29,30]. We 
were desirous of examining the relative contributions of the 
five cationic amine groups in DS96 (Scheme 1), and we 
therefore synthesized DS176 (Scheme 3), in which two of 
the internal secondary amines are replaced by amides, obvi-
ating cationic charges at these positions. We found that 
DS176 was significantly less active than DS96 (Fig. 1), 
emphasizing the importance of the potential salt-bridges 
between the internal secondary amines of the lipopolyamine 
and the Kdo groups in LPS as we had previously postulated 
[13,14]. Exhaustive Michael addition of DS96 yielded the 
analogue Yan673, in which all the amines are peralkylated 
(Scheme 1); this compound was found to be virtually inac-
tive, pointing to the indispensability of protonatable amine 
groups for ionic H-bond formation in the complex. Replace-
ment of the long-chain N-alkyl group with a biphenyl ap-
pendage in DS347 results in attenuation of neutralizing ac-
tivity, indicating that an aliphatic alkyl group is optimal for 
hydrophobic interactions with the polyacyl domain of LPS 
[13,14]. 
 The differences observed in the phase transition experi-
ments (Figs. 2, 3), in which DS176 leads to a stronger fluidi-
zation of the acyl chains than compound DS96, appear not to 
correspond to neutralizing activity, since the active LPA 
DS347 has also high fluidization efficiency (Fig. 2, 3). This 
is an accordance to former data for the inactivation effi-
ciency for different antimicrobial peptides, for example po-
lymyxin B (PMB) and its nonapeptide PMBN [23], and 
newly developed compounds called synthetic anti-LPS pep-
tides (SALP) [16]. The degree of fluidization of LPS super-
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Fig. (5). Intercalation of the lipopolyamines into LPS aggregates (A), phosphatidylcholine liposomes (B), and phosphatidylserine liposomes 
(C) in Förster resonance energy transfer spectroscopic (FRET) experiments. As sensitive measure of incorporation the ratio of donor to 
acceptor intensity ID/IA is plotted versus time. The LPAs were added to the lipid aggregates after 50 s. Data were generated in two independ-
ent experiments (two coloured lines are shown for each compound).  
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structures is therefore not a main determinant, but could still 
be contributory to LPS inhibition. This is in contrast to what 
is observed for the aggregate structures of LPS, which may 
be organized as bilayered arrangements within cubic or hex-
agonal symmetry depending on the lengths of the sugar 
chains [27,28], but which never adopt a multilamellar or-
ganization except in cases of underacylated (tetra- or pentaa-
cyl) lipid A moiety, which by themselves do not stimulate 
immune cells but rather may be able to antagonize the activ-
ity of active LPS [31,32]. The data presented in Fig. (4A) 
clearly indicate that the inactive DS176 does not cause any 
change of the LPS aggregate structure, while the addition of 
DS347 leads to a multilamellarization of LPS (Fig. 4B). This 
supramolecular arrangement of LPS was not only found for 
LPS and lipid A, which are inactive a priori, but was 
adopted in particular for all bioactive LPS and lipid A, which 
were inactivated by the addition of antimicrobial peptides or 
proteins [33-37]. A plausible explanation for these observa-
tions is that in large multilamellar aggregates, the regions 
within LPS responsible for the recognition by lipopolysac-
charide-binding protein (LBP), CD14, and the TLR4/MD2 
complex [38,39], are cryptic, obviating interactions of LPS 
with the cells and, consequently, leading to no cellular acti-
vation.  
 The thermodynamic outcomes of binding leading to the 
inactivation of LPS (Fig. 6) is particularly instructive. For 
both highly inactivating LPAs, there is a strong, saturable 
exothermic reaction with LPS, which runs into saturation 
within a sigmoidal curve at already low concentrations of the 
LPAs. Our interpretation of this behavior is that there is an 
initial polar interaction of the amine-containing aliphatic part 
with the backbone of LPS, followed by hydrophobic interac-
tions of the hydrophobic moieties of DS96 (hexadecyl alkyl 
chain) or DS347 (biphenyl group) react with the polyacyl 
domain of lipid A. Such hetero-amphiphilic interactions have 
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(B) 
Fig. (6). Titration of DS96 (A) and DS347 (B) to LPS R60 and enthalpy change versus [LPA]:[LPS] molar ratio with isothermal titration 
calorimetry (ITC). The LPA solution (1 mM) was titrated in 3 µl portions to the LPS dispersion (0.05 mM), and the resulting enthalpy 
change was recorded.  
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been shown to be very crucial for the interaction of LPS with 
the SALP [9,16]. Indeed, for the LPS-binding peptides, the 
first step consists of a direct Coulombic interaction of the 
positively charged amino acids of the SALP with the nega-
tively charged LPS backbone groups (phosphates, carboxy-
lates). This does not take place only in isolated LPS aggre-
gates, but also with LPS or Gram-positive lipoprotein within 
outer membranes of the respective bacteria [40]. 
 It has been shown that one of the properties of the SALP 
and other peptides consists of their ability to intercalate not 
only into membrane phospholipids such as PC and PS, but 
also into LPS aggregates [16]. Similar observations were 
noted with the lipopolyamines (Figs. 5), wherein the LPAs 
are incorporated into target cell membranes irrespective of 
their activity. In particular, the identical incorporation pat-
terns of DS176 and DS347 into LPS aggregates (Fig. 5, top) 
suggest that the conversion of LPS from lamellar to aggre-
gate superstructures (Fig. 4) correspond to biological activity 
of the LPAs.  
CONCLUSIONS 
 We have brought to bear a variety of biophysical tech-
niques to probe the interactions of LPS with candidate 
lipopolyamines which differ in their potencies of LPS neu-
tralization. The results indicate that the ability to induce 
changes in supramolecular aggregate structure of LPS as a 
consequence of its interaction with the lipopolyamines is a 
biophysical correlate of endotoxin neutralization, and will be 
of value in the design and development of endotoxin seques-
tering agents from first principles.  
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